Glucose Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.340681 million compared to USD 0.23493 million a year ago. Net income was USD 0.008092 million compared to net loss of USD 0.131735 million a year ago.
For the nine months, sales was USD 0.918516 million compared to USD 0.759498 million a year ago. Net loss was USD 0.293785 million compared to USD 0.276716 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 0.03 a year ago.